Eligibility for the Medicare GLP-1 Bridge Program depends on CMS criteria
The program is medically supervised by licensed healthcare professionals, ensuring that each step is monitored and tailored to the individuals needs
By product type, the injectable GLP-1 analogues segment held the biggest market share of 70% in 2025
80 Studies of pantethine consumption have demonstrated significant reductions in total cholesterol and LDL cholesterol (up to 13.5%), triglycerides, and elevation of HDL cholesterol in people with high cholesterol 81,82 and diabetic individuals 83 when taken at 9001,200 mg/day, although significant effects on triglycerides have been observed at dosages as low as 600 mg/day
And when your appetite is smaller, every bite counts
The approval expands delivery formats and gives payers and prescribers an additional option that can shift demand away from pen-constrained supply